Clinical trials
Active, not recruiting Phase 3 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
113 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2011 | 2 |
| 2013 | 3 |
| 2014 | 9 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 9 |
| 2021 | 19 |
| 2022 | 14 |
| 2023 | 13 |
| 2024 | 9 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 113 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 17 |
| Alliance for Clinical Trials in Oncology | 7 |
| Eli Lilly and Company | 7 |
| Hoffmann-La Roche | 4 |
| IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 3 |
| National Cancer Institute (NCI) | 3 |
| Pfizer | 3 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 3 |
| The Netherlands Cancer Institute | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 113 |
| Neoplasm Metastasis | 12 |
| Neoplasms | 7 |
| Triple Negative Breast Neoplasms | 7 |
| Breast Diseases | 4 |
| Carcinoma, Intraductal, Noninfiltrating | 3 |
| Brain Neoplasms | 2 |
| Breast Neoplasms, Male | 2 |
| Carcinoma, Ductal, Breast | 2 |
| Carcinoma, Lobular | 2 |
Trials
Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.
13 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.